
Likarda, Inc.
Patented formulation delivery technology used for cell and biologic therapies hydrogel encapsulation (Core Shell Spherification) resulting in protection from immune rejection, customized drug release profiles such as targeted delivery and target hold, extended release and cryopreservation need.































